Skip to content

Frozen Section Examination of Sentinel Lymph Nodes in Breast Cancer

Frozen Section Examination of Sentinel Lymph Nodes in Breast Cancer: A Prospective Randomized Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07591506
Enrollment
142
Registered
2026-05-15
Start date
2026-05-01
Completion date
2027-05-01
Last updated
2026-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasms

Keywords

sentinel lymph node biopsy, frozen section, breast cancer, intraoperative pathology, axillary staging

Brief summary

This prospective randomized clinical study evaluates the role of intraoperative frozen section examination of sentinel lymph nodes in patients with breast cancer. The study aims to determine whether frozen section assessment during surgery improves intraoperative decision-making and affects surgical management when compared with standard final pathological evaluation performed after surgery.

Interventions

DIAGNOSTIC_TESTIntraoperative Frozen Section Examination of Sentinel Lymph Node

Sentinel lymph nodes are rapidly transported to pathology without formaldehyde fixation and are evaluated intraoperatively by frozen section.

DIAGNOSTIC_TESTRoutine Postoperative Histopathological Evaluation of Sentinel Lymph Node

Sentinel lymph nodes are processed after formaldehyde fixation and evaluated with routine histopathology after surgery.

Sponsors

Izmir City Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Masking description

No masking is applied. Surgeons and pathologists are aware of the intraoperative frozen section assessment.

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with breast carcinoma * No prior neoadjuvant treatment

Exclusion criteria

* Inability to localize the sentinel lymph node preoperatively by lymphoscintigraphy or blue dye * Previous axillary surgery * Recurrent breast cancer * Patients who cannot receive radiotherapy * Prior neoadjuvant treatment

Design outcomes

Primary

MeasureTime frameDescription
Number of participants randomized to the frozen section group and the routine histopathology groupFrom first participant enrollment until the target sample size is reached, up to 1 yearCount of participants randomized by sealed-envelope method to either intraoperative frozen section evaluation of sentinel lymph nodes or routine histopathological evaluation after formalin fixation. This outcome will be reported as the total number of randomized participants until the protocol-defined target sample size for between-group comparison is reached (planned total sample size: 142 participants).

Secondary

MeasureTime frameDescription
Percentage of participants in the routine histopathology group who require axillary lymph node dissectionFrom surgery until final histopathological evaluation and multidisciplinary treatment decision, up to 30 daysPercentage of participants assigned to the routine histopathology group without intraoperative frozen section who require axillary lymph node dissection based on final histopathological evaluation and multidisciplinary treatment decision.

Countries

Turkey (Türkiye)

Contacts

PRINCIPAL_INVESTIGATOROrhan Ureyen, Prof. / MD

Izmir City Hospital / General Surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 16, 2026